Could a common supplement protect nerves during breast cancer treatment?

NCT ID NCT07307911

Completed Symptom relief Sponsor: Damanhour University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether Coenzyme Q10, a dietary supplement, can reduce nerve damage, fatigue, and pain in women with newly diagnosed breast cancer receiving paclitaxel chemotherapy. Fifty women took either CoQ10 plus chemotherapy or chemotherapy alone for twelve weeks. Researchers measured nerve health through blood tests and questionnaires to see if the supplement helps protect nerves and improve quality of life.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Coenzyme Q10
What this could lead to: If it works, this could point toward a simple supplement to ease nerve pain and fatigue during chemotherapy, improving quality of life.
What could go wrong: This is a small Phase 2 trial with only 50 participants, so results may not apply widely. The supplement may not reduce symptoms significantly, and side effects are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER

Contacts and locations

Locations

Damanhur Oncology Center

Damanhūr, 22511, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.